TrialHuman vaccines & immunotherapeutics2020

Immunogenicity and safety of high-dose quadrivalent influenza vaccine in Japanese adults ≥65 years of age: a randomized controlled clinical trial.

Leilani Sanchez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.